Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Journey Medical Corp (DERM)
NASDAQ:DERM
RESEARCH TOOLSreports
Holding DERM?
Track your performance easily
DERM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.85 - $7.15
Previous Close$4.49
Volume56.66K
Average Volume (3M)110.69K
Market Cap
$93.80M
Enterprise Value$91.15M
Total Cash (Recent Filing)$22.46M
Total Debt (Recent Filing)$19.82M
Price to Earnings (P/E)―
Beta0.89
Next Earnings
Mar 20, 2025EPS Estimate
-$0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.92
Shares Outstanding20,889,936
10 Day Avg. Volume60,705
30 Day Avg. Volume110,687
Standard Deviation0.19
R-Squared0.06
Alpha0.00091
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)8.63
Price to Sales (P/S)1.62
Price to Cash Flow (P/CF)-20.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.58
Enterprise Value/Gross Profit1.74
Enterprise Value/Ebitda-6.77
Forecast
1Y Price Target
$9.67Price Target Upside121.28% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Journey Medical Corp News
PremiumCompany Announcements
Journey Medical Reports Q3 2024 Earnings, Eyes Emrosi Launch
Ownership Overview
45.26% Insiders
2.73% Mutual Funds
4.02% Other Institutional Investors
45.66% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DERM FAQ
What was Journey Medical Corp’s price range in the past 12 months?
Journey Medical Corp lowest stock price was $2.85 and its highest was $7.15 in the past 12 months.
What is Journey Medical Corp’s market cap?
Currently, no data Available
When is Journey Medical Corp’s upcoming earnings report date?
Journey Medical Corp’s upcoming earnings report date is Mar 20, 2025 which is in 84 days.
How were Journey Medical Corp’s earnings last quarter?
Journey Medical Corp released its earnings results on Nov 12, 2024. The company reported -$0.12 earnings per share for the quarter, beating the consensus estimate of -$0.17 by $0.05.
Is Journey Medical Corp overvalued?
According to Wall Street analysts Journey Medical Corp’s price is currently Undervalued.
Does Journey Medical Corp pay dividends?
Journey Medical Corp does not currently pay dividends.
What is Journey Medical Corp’s EPS estimate?
Journey Medical Corp’s EPS estimate is -$0.2.
How many shares outstanding does Journey Medical Corp have?
Journey Medical Corp has 14,889,936 shares outstanding.
What happened to Journey Medical Corp’s price movement after its last earnings report?
Journey Medical Corp reported an EPS of -$0.12 in its last earnings report, beating expectations of -$0.17. Following the earnings report the stock price went down -6.055%.
Which hedge fund is a major shareholder of Journey Medical Corp?
Among the largest hedge funds holding Journey Medical Corp’s share is Royce & Associates LLC. It holds Journey Medical Corp’s shares valued at N/A.
---
Journey Medical Corp Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.67 (121.28% Upside)
$9.67 (121.28% Upside)
Hedge Fund Trend
Decreased
By 12.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 8.6%
Last 30 Days ▼ 8.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-43.59%
12-Months-Change
Fundamentals
Return on Equity
-129.58%
Trailing 12-Months
Asset Growth
-2.84%
Trailing 12-Months
Company Description
Journey Medical Corp
Journey Medical Corp is focused on identifying, acquiring, developing and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model.
---
DERM Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted Journey Medical's solid progress with a positive adjusted EBITDA, cost management, and growth potential for DFD-29 despite a year-over-year decline in net product revenue and a reported net loss. The overall sentiment leans towards optimism due to strategic advancements and anticipated market opportunities.Read More>---
DERM Stock 12 Month Forecast
Average Price Target
$9.67
▲(121.28% Upside)
Technical Analysis
Best Analysts Covering DERM
1 Year
1 Year Success Rate
4/8 ratings generated profit
1 Year Average Return
+18.19%
reiterated a buy rating 2 months ago
Copying Scott Henry's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +18.19% per trade.
---